vs
Side-by-side financial comparison of Ambow Education Holding Ltd. (AMBO) and CG Oncology, Inc. (CGON). Click either name above to swap in a different company.
Ambow Education Holding Ltd. is the larger business by last-quarter revenue ($2.8M vs $2.3M, roughly 1.2× CG Oncology, Inc.). Ambow Education Holding Ltd. runs the higher net margin — 64.2% vs -1779.0%, a 1843.2% gap on every dollar of revenue. On growth, CG Oncology, Inc. posted the faster year-over-year revenue change (409.2% vs 15.3%).
Ambow Education Holding Ltd. is a China-focused education service provider that offers personalized learning solutions, professional career training programs, and K-12 after-school tutoring services. It partners with educational institutions and enterprises to deliver technology-integrated learning resources for learners of all age groups across mainland China.
CG Oncology, Inc. is a clinical-stage biotechnology company focused on developing innovative targeted immunotherapies for urological cancers including non-muscle invasive bladder cancer. It primarily operates in the U.S. market, advancing pipeline candidates to address unmet medical needs for patients with limited treatment options.
AMBO vs CGON — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8M | $2.3M |
| Net Profit | $1.8M | $-41.3M |
| Gross Margin | 53.3% | — |
| Operating Margin | 11.9% | -2097.3% |
| Net Margin | 64.2% | -1779.0% |
| Revenue YoY | 15.3% | 409.2% |
| Net Profit YoY | 1343.1% | -29.9% |
| EPS (diluted) | $0.03 | $-0.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $1.7M | ||
| Q2 25 | $2.8M | $0 | ||
| Q4 24 | — | $456.0K | ||
| Q2 24 | $2.4M | — | ||
| Q1 24 | — | $529.0K | ||
| Q2 23 | $2.7M | — | ||
| Q2 22 | $16.4M | — |
| Q4 25 | — | $-41.3M | ||
| Q3 25 | — | $-43.8M | ||
| Q2 25 | $1.8M | $-41.4M | ||
| Q4 24 | — | $-31.8M | ||
| Q2 24 | $123.0K | — | ||
| Q1 24 | — | $-16.9M | ||
| Q2 23 | $-1.0M | — | ||
| Q2 22 | $-11.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 53.3% | — | ||
| Q4 24 | — | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 44.7% | — | ||
| Q2 22 | 9.2% | — |
| Q4 25 | — | -2097.3% | ||
| Q3 25 | — | -3069.0% | ||
| Q2 25 | 11.9% | — | ||
| Q4 24 | — | -8344.1% | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | — | -4247.4% | ||
| Q2 23 | -27.7% | — | ||
| Q2 22 | -13.7% | — |
| Q4 25 | — | -1779.0% | ||
| Q3 25 | — | -2629.5% | ||
| Q2 25 | 64.2% | — | ||
| Q4 24 | — | -6973.7% | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | — | -3200.8% | ||
| Q2 23 | -36.7% | — | ||
| Q2 22 | -67.1% | — |
| Q4 25 | — | $-0.52 | ||
| Q3 25 | — | $-0.57 | ||
| Q2 25 | $0.03 | $-0.54 | ||
| Q4 24 | — | $-0.47 | ||
| Q2 24 | $0.00 | — | ||
| Q1 24 | — | $-0.36 | ||
| Q2 23 | $-0.02 | — | ||
| Q2 22 | $-0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $742.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.6M | $752.6M |
| Total Assets | $23.2M | $791.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $742.2M | ||
| Q3 25 | — | $680.3M | ||
| Q2 25 | $4.1M | $661.1M | ||
| Q4 24 | — | $742.0M | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | — | $566.5M | ||
| Q2 23 | $6.9M | — | ||
| Q2 22 | $9.2M | — |
| Q4 25 | — | $752.6M | ||
| Q3 25 | — | $687.6M | ||
| Q2 25 | $8.6M | $670.4M | ||
| Q4 24 | — | $733.4M | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | — | $568.9M | ||
| Q2 23 | $7.4M | — | ||
| Q2 22 | $9.4M | — |
| Q4 25 | — | $791.6M | ||
| Q3 25 | — | $729.9M | ||
| Q2 25 | $23.2M | $701.4M | ||
| Q4 24 | — | $754.8M | ||
| Q2 24 | $17.6M | — | ||
| Q1 24 | — | $579.1M | ||
| Q2 23 | $28.8M | — | ||
| Q2 22 | $136.4M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-36.2M |
| Free Cash FlowOCF − Capex | — | $-36.2M |
| FCF MarginFCF / Revenue | — | -1560.0% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-124.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-36.2M | ||
| Q3 25 | — | $-38.9M | ||
| Q2 25 | — | $-28.0M | ||
| Q4 24 | — | $-20.7M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-26.0M | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | $-36.2M | ||
| Q3 25 | — | $-39.0M | ||
| Q2 25 | — | $-28.0M | ||
| Q4 24 | — | $-20.9M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-26.0M | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | -1560.0% | ||
| Q3 25 | — | -2340.4% | ||
| Q2 25 | — | — | ||
| Q4 24 | — | -4577.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -4919.5% | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 5.8% | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 45.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.3% | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
